title: Hepatocellular carcinoma presenting as paraneoplastic myasthenia gravis.
authors.affiliation: Department of Medical Oncology, GF Leclerc Regional Anticancer Centre, Dijon, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Vautravers
authors.forename: Patrick
authors.initials: P
authors.lastname: Rat
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Cercueil
authors.forename: Thibault
authors.initials: T
authors.lastname: Moreau
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Horiot
authors.forename: Bruno
authors.initials: B
authors.lastname: Chauffert
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000379:methods; D003287:Contrast Media / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D020361:Paraneoplastic Syndromes, Nervous System / Q000175:diagnosis*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D003287:Contrast Media; D004317:Doxorubicin; C027260:pirarubicin